Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

CTP-543 is generally safe for treating alopecia areata.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Gefitinib can cause scalp skin issues and permanent hair loss.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Nilotinib can cause skin issues like red bumps and hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Baricitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.